KALA BIO, Inc.
NASDAQ:KALA · NASDAQ Global Select
+$0.58 today
Vol 0.96M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-98.20%
Period High
$981.50
Period Low
$2.06
Latest
$3.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
VYNE Therapeutics Inc.
VYNE
$10.78M
Impact BioMedical Inc.
IBO
$7.07M
XTL Biopharmaceuticals Ltd.
XTLB
$5.84M
Soligenix, Inc.
SNGX
$4.16M
Pasithea Therapeutics Corp.
KTTA
$3.74M
Oragenics, Inc.
OGEN
$2.73M
Can-Fite BioPharma Ltd.
CANF
$2.62M
Ensysce Biosciences, Inc.
ENSC
$2.58M
AIM ImmunoTech Inc.
AIM
$1.26M
Abpro Corporation
ABP
$1.06M
What is the latest KALA filing?
The latest filing shown is S-3/A dated Jun 12, 2026.
How many recent filings does KALA have?
Intrinsic Alpha currently shows 20 recent filings for KALA.
Explore More
Continue the stock analysis
Jump to another research area for this company.